ImmunityBio (NASDAQ: IBRX) is a mid-cap drugmaker making waves in this niche right now; the company's shares have soared over the last 12 months. Although ImmunityBio appears promising, investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results